Sabrina Krause, T. Friedl, T. Romashova, P. Fasching, A. Schneeweiss, V. Müller, F. Taran, P. Arkadius, T. Marie, A. D. Gregorio, F. Meier-Stiegen, J. Huober, W. Janni, T. Fehm
{"title":"OT1-10-01: DETECT III/IV研究试验- her2阴性转移性乳腺癌和循环肿瘤细胞患者的多中心研究项目","authors":"Sabrina Krause, T. Friedl, T. Romashova, P. Fasching, A. Schneeweiss, V. Müller, F. Taran, P. Arkadius, T. Marie, A. D. Gregorio, F. Meier-Stiegen, J. Huober, W. Janni, T. Fehm","doi":"10.1158/1538-7445.SABCS18-OT1-10-01","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19476,"journal":{"name":"Ongoing Clinical Trials","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Abstract OT1-10-01: DETECT III/IV study trial – The multicenter study program in patients with HER2-negative metastatic breast cancer and circulating tumor cells\",\"authors\":\"Sabrina Krause, T. Friedl, T. Romashova, P. Fasching, A. Schneeweiss, V. Müller, F. Taran, P. Arkadius, T. Marie, A. D. Gregorio, F. Meier-Stiegen, J. Huober, W. Janni, T. Fehm\",\"doi\":\"10.1158/1538-7445.SABCS18-OT1-10-01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19476,\"journal\":{\"name\":\"Ongoing Clinical Trials\",\"volume\":\"26 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ongoing Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.SABCS18-OT1-10-01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ongoing Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.SABCS18-OT1-10-01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract OT1-10-01: DETECT III/IV study trial – The multicenter study program in patients with HER2-negative metastatic breast cancer and circulating tumor cells